Sodium warnings "across-the-board" for orally-ingested OTCs unnecessary -- NDMA.
This article was originally published in The Tan Sheet
Executive Summary
"ACROSS-THE-BOARD" SODIUM WARNING FOR ORAL OTCs QUESTIONED BY NDMA in Sept. 20 comments on FDA's sodium labeling final rule. Although the Nonprescription Drug Manufacturers Association "agrees in principle it could be useful to [identify] the quantity of sodium in labeling of certain OTC drug products," the association "disagrees with the across-the-board sodium warning requirement for all orally-ingested OTC drugs."